Left ventricular performance of pulmonary atresia with intact ventricular septum after right heart bypass surgery  by Tanoue, Yoshihisa et al.
Surgery for Congenital Heart Disease Tanoue et al
CH
DLeft ventricular performance of pulmonary atresia with






Shiro Ishikawa, MDFrom the Departments of Cardiovascular
Surgery and Pediatric Cardiology, Fukuoka
Children’s Hospital Medical Center,
Fukuoka, Japan.
Read at the Eighty-fourth Annual Meeting
of The American Association for Thoracic
Surgery, Toronto, Ontario, Canada, April
25-28, 2004.
Received for publication April 21, 2004;
revisions received July 17, 2004; accepted
for publication July 22, 2004.
Address for reprints: Yoshihisa Tanoue,
MD, Department of Cardiovascular Sur-
gery, Kyushu University, 3-1-1 Maidashi,
Higashi-ku, Fukuoka 812-8582, Japan (E-
mail: tanoue@heart.med.kyushu-u.ac.jp).
J Thorac Cardiovasc Surg 2004;128:710-7
0022-5223/$30.00
Copyright © 2004 by The American Asso-
ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2004.07.035
710 The Journal of Thoracic and CardioObjective: The left ventricular performance in patients with pulmonary atresia with
intact ventricular septum who were Fontan candidates before and after the bidirec-
tional Glenn procedure and a staged total cavopulmonary connection was compared
with that in patients with tricuspid atresia.
Methods: Contractility (end-systolic elastance), afterload (effective arterial elas-
tance), and ventricular efficiency (ventriculoarterial coupling, arterial elastance/end-
systolic elastance ratio), and the ratio of stroke work and pressure-volume area were
approximated on the basis of cardiac catheterization data before the bidirectional Glenn
procedure, before and after staged total cavopulmonary connection, and approximately
1 year after the completion of total cavopulmonary connection in 20 patients with
pulmonary atresia with intact ventricular septum and 21 patients with tricuspid atresia.
Results: The end-systolic elastance of the pulmonary atresia with intact ventricular
septum group was significantly inferior to that of the tricuspid atresia group after
bidirectional Glenn procedure and total cavopulmonary connection (1 year after
total cavopulmonary connection 1.85  0.51 mm Hg · m2 · mL1 vs 2.84  0.96
mm Hg · m2 · mL1, P  .01). The arterial elastance was not different between
groups throughout the assessment period and tended to increase in a stepwise
fashion after bidirectional Glenn procedure and total cavopulmonary connection.
The arterial elastance/end-systolic elastance ratio and ratio of stroke work and
pressure-volume area of the pulmonary atresia with intact ventricular septum group
tended to worsen, whereas those of the tricuspid atresia group tended to improve.
The difference reached statistical significance 1 year after total cavopulmonary
connection (1.15  0.35 vs 0.82  0.23 and 64.2%  6.7% vs 71.3%  5.7%,
respectively, P  .05 and P  .05, respectively).
Conclusion: The contractility and ventricular efficiency of patients with pulmonary
atresia with intact ventricular septum are inferior to those of patients with tricuspid
atresia after bidirectional Glenn procedure and total cavopulmonary connection. A
high-pressure residual right ventricle may impair the left ventricular performance of
patients with pulmonary atresia with intact ventricular septum after bidirectional
Glenn procedure and total cavopulmonary connection.
Left ventricular (LV) performance in patients with pulmonary atresiawith intact ventricular septum (PA/IVS) is of crucial significancebecause the tricuspid valve and right ventricle (RV) of such indi-viduals are hypoplastic to varying degrees. The treatment of patientswith PA/IVS is dictated by the size of the tricuspid annulus, the sizeand shape of the RV, and the presence of coronary artery obstructive
lesions. In patients with severe hypoplasia of the tricuspid valve and RV, the Fontan
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Dprocedure is used to separate the systemic and pulmonary
circulations, thereby eliminating arterial hypoxemia and
ventricular volume overloading.1-11 In patients with PA/
IVS, the sole pumping chamber of Fontan candidates is the
left-dominant ventricle, which is considered more suitable
as a systemic pumping chamber than the right-dominant
single ventricle. However, LV function in patients with
PA/IVS is not always as good as expected.
We hypothesize that the detail analysis of the interplay
between contractility and afterload provided by end-systolic
elastance (Ees), effective arterial elastance (Ea), ventriculo-
arterial coupling (Ea/Ees), and the ratio of stroke work and
pressure-volume area (SW/PVA) manifests the impaired
LV performance in patients with PA/IVS. In this study, the
LV performances of patients with PA/IVS before and after
the bidirectional Glenn procedure (BDG) and a staged total
cavopulmonary connection (TCPC) were compared with
those of patients with tricuspid atresia (TA). TA is also a
single-ventricle disease that affects the left-dominant ven-
tricle. The purpose of this study was to analyze the LV
performance (contractility, afterload, ventricular efficiency)




Twenty consecutive patients with PA/IVS (10 male and 10 female)
and 21 consecutive patients with TA (11 male and 10 female)
underwent both BDG and TCPC at the Fukuoka Children’s Hos-
pital Medical Center between November 1992 and May 2003. The
patients were operated on during the same period, and no operative
or in-hospital deaths were seen. Informed consent for both the
operation and cardiac catheterization was obtained from the par-
ents of all children.
In the PA/IVS group, coronary artery obstructive lesions in asso-
ciation with the RV–coronary artery fistulas were present in 6 pa-
tients, mitral regurgitation was present in 4, and paroxysmal supraven-
tricular tachycardia was present in 1. In the TA group, the
ventriculoarterial connections were concordant in 20 patients and
discordant in 1, mitral regurgitation was present in 2, partial anoma-
lous pulmonary venous return was present in 1, and an aortopulmo-
nary window was present in 1. Before BDG, a systemic-to-pulmonary
shunt was performed in 29 patients (20 patients with PA/IVS and 9
patients with TA), and pulmonary artery banding was performed in 7
of the patients with TA. Mean ages of the patients with PA/IVS were
37.9 37.7 months (6-142 months) at BDG and 60.8 36.2 months
(25-153 months) at TCPC. Mean weights at these procedures were
10.3  5.0 kg (5.1-22.6 kg) and 14.3  4.9 kg (8.4-29.7 kg),
respectively. Mean ages of the patients with TA were 41.6  38.4
months (6-129 months) at BDG and 64.2  35.9 months (27-142
months) at TCPC. The mean weights at these procedures were 11.9
6.5 kg (5.8-27.5 kg) and 15.6  6.7 kg (9.2-33.6 kg), respectively.
Operative Techniques
Anesthesia was conducted by a standard technique with intrave-
nous infusions of fentanyl, inhalation of sevoflurane, and muscle
The Journal of Thoracirelaxation with pancuronium. Aortic and bicaval cannulations
were performed through a standard median sternotomy, and car-
diopulmonary bypass (CPB) was instituted with a heart-lung ma-
chine consisting of a rotating pump and a membrane oxygenator.
When heart arrest was necessary, myocardial preservation was
achieved with a cold crystalloid cardioplegic solution12,13 com-
bined with topical cooling. In the patients with PA/IVS with
coronary artery obstructive lesions in association with the RV–
coronary artery fistulas, the central venous pressure was kept high
to avoid decompressing the RV during CPB with a beating heart,
and cardioplegic heart arrest was induced immediately after the
introduction of CPB if heart arrest was necessary.
BDG. Bidirectional cavopulmonary shunts were made by direct
end-to-side anastomosis between the superior vena cava and the
pulmonary artery. Bilateral superior venae cavae were present in 2 of
the patients with TA, and bidirectional cavopulmonary anastomoses
were conducted separately. With respect to concomitant procedures,
augmentation of the pulmonary artery was performed in 17 patients (8
with PA/IVS and 9 with TA), mitral valvuloplasty was performed in
6 (4 with PA/IVS and 2 with TA), and an enlargement of atrial septal
defect was performed in 20 (13 with PA/IVS and 7 with TA).
Additional pulmonary blood flow was maintained in 7 patients with
PA/IVS (all systemic-to-pulmonary shunt) and 15 with TA (5 sys-
temic-to-pulmonary shunts and 10 main pulmonary arteries). Mean
CPB time of the patients with PA/IVS was 95.5  49.3 minutes
(33-148 minutes), and that of the patients with TA was 98.0  37.8
minutes (32-154 minutes). Mean aortic crossclamp time of the pa-
tients with PA/IVS was 6.1  11.9 minutes (0-41 minutes), and that
of the patients with TA was 6.0  13.6 minutes (0-44 minutes).
TCPC. For inferior cavopulmonary anastomoses, the lateral
tunnel technique14 was performed in 1 patient with PA/IVS and
3 patients with TA, and the extracardiac conduit approach with
a 16- to 20-mm polytetrafluoroethylene graft15 was performed
in 19 patients with PA/IVS and 18 patients with TA. Fenestra-
tion was not created in any patient. Augmentation of the pul-
monary artery was performed in 12 patients (4 with PA/IVS and
8 with TA), mitral valvuloplasty was performed in 2 (1 from
each group), an enlargement of atrial septal defect was per-
formed in 3 (2 with PA/IVS and 1 with TA), and release of
pulmonary venous obstruction was performed in 1 patient with
TA. Mean CPB time of the patients with PA/IVS was 78.6 
28.0 minutes (39-130 minutes), and that of the patients with TA
was 98.9  39.3 minutes (42-206 minutes). Mean aortic cross-
clamp time of the patients with PA/IVS was 5.4  14.1 minutes
(0-45 minutes), and that of the patients with TA was 9.6  14.8
minutes (0-47 minutes).
Data Analysis
All patients underwent cardiac catheterization before BDG (PreG)
and before and after TCPC (PreT, PostT0), and 35 patients (19
with PA/IVS and 16 with TA) similarly underwent cardiac cath-
eterization approximately 1 year after TCPC (PostT1). Biplane left
ventriculography was performed, and LV volumes were calculated
with the area-length method.16 RV volume was excluded in both
groups as a unified method. Calculations of the percentage of
normal LV end-diastolic volume (%N-EDV) were conducted on
the basis of control data obtained from patients matched by body
c and Cardiovascular Surgery ● Volume 128, Number 5 711
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treatment for Kawasaki disease with intact coronary artery at
Fukuoka Children’s Hospital Medical Center. LV ejection fraction
(LVEF) was calculated as follows: LVEF  (1  minimal LV
volume/maximal LV volume)  100%. The calculations of con-
tractility (Ees), afterload (Ea), and ventricular efficiency (Ea/Ees
and SW/PVA) were performed on the basis of pressure and vol-
ume data obtained from cardiac catheterization by the approxima-
tion method, as previously described elsewhere.17-19 Approxima-
tions of Ees and Ea were performed as follows: Ees  mean
arterial pressure/minimal LV volume, and Ea  maximal LV
pressure/(maximal LV volume  minimal LV volume). LV vol-
ume was divided by the body surface area. Ea/Ees represents the
ventriculoarterial coupling between the LV and arterial system
described by Burkhoff and Sagawa.20 SW/PVA was calculated
as follows: SW/PVA  1/(1  0.5Ea/Ees)  100%. This
theoretic formula was previously described by Nozawa and
Figure 1. Time courses of %N-EDV and LVEF. %N-EDV in PA/IVS
group tended to be larger than that in TA group, and it decreased
stepwise in both groups after BDG and TCPC. LVEF in PA/IVS
group was lower than that in TA group. Black circles represent
mean values of PA/IVS group; open circles represent mean values
of TA group; error bars represent SD. Asterisk indicates P < .05
by Bonferroni test.colleagues.21
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The results are presented as mean  SD. Two-factor analysis of
variance with repeated measures of one factor (RM-ANOVA) was
used for the measured variables of PreG, PreT, PostT0, and PostT1
(4 points). The analysis clarified whether each of the repeated
measures and nonrepeated factors were significantly different
among or between levels, and also whether interactions between
the two factors were significant. This analysis was used to deter-
mine whether the variables were statistically different among the
four time points and between patients with PA/IVS and patients
with TA. The Bonferroni test was used as a post hoc test.
Results
Hemodynamic variables (mean pulmonary arterial pressure,
Figure 2. Time courses of Ees and Ea. Ees in PA/IVS group was
significantly lower than that in TA group. Although Ees was not
different between groups before BDG and improved stepwise in
both groups after BDG and TCPC, Ees in PA/IVS group was
significantly inferior to that in TA group after BDG and TCPC. Ea
was not different between groups throughout assessment period
and increased stepwise after BDG and TCPC. Black circles rep-
resent mean values of PA/IVS group; open circles represent mean
values of TA group; error bars represent SD. Asterisk indicates P
< .05 by Bonferroni test.mean aortic pressure, Nakata pulmonary arterial index,22
mber 2004
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valve regurgitation) during cardiac catheterization before
and after BDG and TCPC are shown in Table 1. Mean
pulmonary arterial pressure in the PA/IVS group was sig-
nificantly lower than in the TA group (P  .016 by RM-
ANOVA), and in both groups it decreased in a stepwise
fashion (P  .001 by RM-ANOVA). There was no statis-
tically significant difference between the two groups in
mean aortic pressure, pulmonary arterial index, and sys-
temic arterial oxygen saturation. Mean aortic pressure and
systemic arterial oxygen saturation increased after TCPC in
a stepwise manner (P .001 and P .001, respectively, by
RM-ANOVA).
The time courses of %N-EDV, LVEF, Ees, Ea, Ea/Ees,
and SW/PVA in both groups are shown in Figures 1, 2, and
3. The %N-EDV of the PA/IVS group tended to be larger
than that of the TA group (P  .051 by RM-ANOVA), and
the difference between the two groups before TCPC (PreT)
was statistically significant (PA/IVS group 178%  28%,
TA group 142%  37%, P  .05 by Bonferroni test). In
both groups, the %N-EDV decreased after BDG and TCPC
in a stepwise fashion (P  .001 by RM-ANOVA). The
LVEF of the PA/IVS group was significantly lower than
that of the TA group (P  .004 by RM-ANOVA), and the
Ees of the PA/IVS group was significantly lower than that
of the TA group (P  .001 by RM-ANOVA). Although the
Ees values of both groups were not different before BDG
(PreG) and improved in a stepwise fashion after BDG and
TCPC (P  .001 by RM-ANOVA), the Ees of the PA/IVS
group was significantly inferior to that of the TA group after
BDG and TCPC (PreT 1.41  0.28 mm Hg · m2 · mL1 vs
1.97  0.64 mm Hg · m2 · mL1, P  .05 by Bonferroni
test, PostT0 1.59 0.43 mm Hg · m2 · mL1 vs 2.21 0.72
mm Hg · m2 · mL1, P  .05 by Bonferroni test, PostT1
1.85  0.51 mm Hg · m2 · mL1 vs 2.84  0.96 mm Hg ·
m2 · mL1, P  .01 by Bonferroni test). Ea was not
different between the groups throughout the assessment
period and increased in a stepwise fashion after BDG and
TCPC (P  .001 by RM-ANOVA). Differences in Ea/Ees
and SW/PVA between the two groups were statistically
significant (P  .003 and P  .002, respectively, by RM-
ANOVA). The Ea/Ees and SW/PVA of the PA/IVS group
tended to worsen, whereas those of the TA group tended to
improve. One year after TCPC, this difference became
statistically significant (PostT1 1.15  0.35 vs 0.82  0.23,
and 64.2% 6.7% vs 71.3% 5.7%, respectively, P .05
and P  .05, respectively, by Bonferroni test).
Discussion
The major findings of this study of patients with PA/IVS
who underwent right heart bypass surgery were as follows:
(1) Contractility (Ees) of patients with PA/IVS was lower
than that of patients with TA after BDG and TCPC. (2)
The Journal of ThoraciVentricular efficiency (Ea/Ees and SW/PVA) of patients
with PA/IVS was inferior to that of patients with TA after
TCPC. To the best of our knowledge, this is the first report
to focus on ventricular performance (contractility, afterload,
ventricular efficiency) of patients with PA/IVS who are
Fontan candidates.
PA/IVS is an anatomically heterogeneous congenital
heart disease that shows morphologic variations in the size
of the tricuspid annulus, the size and shape of the RV cavity,
and coronary artery obstructive lesions in association with
the RV–coronary artery fistulas. The varying degrees of
these morphologic factors dictate whether patients are can-
didates for biventricular repair or for less corrective proce-
dures such as the Fontan operation. Many studies on PA/
IVS have discussed these variations as an indication for
Figure 3. Time courses of Ea/Ees and SW/PVA. Differences be-
tween groups in Ea/Ees and SW/PVA were statistically signifi-
cant. Ea/Ees and SW/PVA in PA/IVS group tended to worsen,
whereas those in TA group tended to improve. Differences be-
tween groups became statistically significant 1 year after TCPC.
Black circles represent mean values of PA/IVS group; open
circles represent mean values of TA group; error bars represent
SD. Asterisk indicates P < .05 by Bonferroni test.surgical strategies such as biventricular repair, one-and-a-
c and Cardiovascular Surgery ● Volume 128, Number 5 713
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heart transplantation.3-11 However, patients with markedly
hypoplastic tricuspid valves and RVs or with obstructive
coronary artery lesions are not candidates for biventricular
repair.1-3 The possibility of patients with PA/IVS becoming
Fontan candidates is also of great importance.
Coronary artery obstructive lesions in association with
the RV–coronary artery fistulas are considered one of the
most important factors of impaired LV function in patients
with PA/IVS. These coronary abnormalities cause ischemic
damage to the LV myocardium. However, LV dysfunction
has been demonstrated even in patients with less severe
coronary abnormalities.23-25 In this study, there was no
significant difference in SW/PVA 1 year after TCPC be-
tween patients with PA/IVS with and without important
RV–coronary artery fistulas (63.9%  6.5% vs 64.3% 
7.0%, respectively), although the Ees 1 year after TCPC in
patients with PA/IVS with important RV–coronary artery
fistulas tended to be inferior to that in patients with PA/IVS
without coronary artery lesions (1.54  0.41 mm Hg ·
m2 · mL1 vs 1.99  0.50 mm Hg · m2 · mL1, statistical
analysis not performed because of small number of pa-
tients). Coronary abnormalities with RV–coronary artery
fistulas are, however, not always the main reasons for LV
functional disturbances in patients with PA/IVS. Histologic
abnormalities of the LV myocardium, cell swelling and
increased interstitial fibrosis, have been demonstrated not
only in patients with PA/IVS with normal coronary arteries
but also in patients with TA.26-29 Small RVs were a con-
sistent feature in patients who had PA/IVS and were Fontan
candidates and in patients with TA; however, RV pressure
was significantly different between the two groups. Ventric-
TABLE 1. Hemodynamic variables during cardiac catheter
Mean pulmonary arterial pressure (mm Hg, mean  SD)
PA/IVS group 1
TA group 1
Mean aortic pressure (mm Hg, mean  SD)
PA/IVS group 6
TA group 6
Nakata pulmonary arterial index (mm2/m2, mean  SD)
PA/IVS group
TA group
Arterial oxygen saturation (%, mean  SD)
PA/IVS group 7
TA group 8
At least mild mitral regurgitation (No.)
PA/IVS group
TA group
*P  .05 versus PreG by Bonferroni test.
†P  .05 versus PreT by Bonferroni test.ular septum interactions between the RV and the LV greatly
714 The Journal of Thoracic and Cardiovascular Surgery ● Noveinfluence LV performance.30,31 High-pressure RVs oppress
the ventricular septum and then disturb LV function. Al-
though many questions remain unanswered regarding the
exact mechanisms of impaired LV function in patients with
PA/IVS after right heart bypass surgery, a high-pressure RV
might impair LV performance in patients with PA/IVS after
BDG and TCPC. Recently, we have performed RV outflow
tract reconstruction at BDG to decompress the high-
pressure RV in a patient with PA/IVS who was a Fontan
candidate and did not have any RV–coronary artery fistulas.
Measurements of ordinary hemodynamic variables, such
as mean aortic pressure and LVEF, are not sufficient for
assessing ventricular function. Ees is a load-independent
parameter of systolic ventricular function and an ideal index
of contractility. However, it is difficult (practically impos-
sible) to measure the LV pressure-volume relations that are
needed to calculate Ees in clinical situations. We previously
reported approximations of Ees and Ea and validated this
approximation in a canine right heart bypass model with a
conductance catheter in the LV cavity.17,32 This approxima-
tion was combined with cardiac catheterization data from
single-ventricle patients, and then the ventricular perfor-
mance of the patients who underwent right heart bypass
surgery was analyzed.17,18 With this simple approximation,
single LV contractility, afterload, and efficiency in patients
with PA/IVS and patients with TA could be evaluated from
the conventional cardiac catheterization data used in this
study.
In our hospital, all Fontan candidates, not only high-risk
candidates such as those with hypoplastic left heart syn-
drome, undergo the staged Fontan procedure. The advan-
tages of this procedure are as follows: (1) preservation of
on
eG PreT PostT0 PostT1
6.2 8.1  2.9* 8.1  2.2* 7.3  2.7*
7.2 9.0 3.0* 8.9  2.6* 8.4  2.3*
10.1 73.3 12.6 71.9 11.1* 74.3 11.3*
9.7 71.6  7.9 73.8  8.7 81.1  10.9*
93 229 66 211 72 203  79
143 244 122 211 71 203  53
7.8 87.1  3.2* 93.3 1.6*† 94.4 1.6*†
6.2 87.7  4.0* 93.9 2.0*† 94.3 2.1*†
.0%) 2 (10.0%) 0 (0.0%) 0 (0.0%)
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myocardial hypertrophy and fibrosis35; (3) avoidance of
deleterious effects as a result of a sudden decrease in ven-
tricular volume35; (4) minimization of afterload mismatch
caused by cavopulmonary anastomosis17; and (5) correction
of afterload mismatch during the interval between BDG and
staged TCPC.18 BDG should be performed in an early stage
to prevent myocardial hypertrophy and fibrosis.36 In this
study, however, the mean age at BDG was around 3 years,
and that at TCPC was about 5 years. The reason for the high
averages is that the study includes cases from relatively
early in our experience. Recently, we began performing
BDG at an early stage insofar as possible. Several strategies
were considered to improve the clinical results of single-
ventricle patients, and the following strategies were pur-
sued: (1) As far as possible, any concomitant procedures
were finished during the BDG operation, and inferior cavo-
pulmonary anastomosis was only performed in patients
undergoing staged TCPC. (2) As far as possible, a staged
Fontan procedure with an extracardiac conduit was per-
formed with a beating heart.37 (3) Large doses of an
-blocking agent (chlorpromazine at 1-2 mg/kg) were used
during CPB,38 and a 2-g/(kg · min) infusion of nitroglyc-
erin and inhalation of 100% oxygen with 5 to 20 ppm nitric
oxide were performed on weaning from CPB.39 (4) Long-
term oral intakes of an angiotensin-converting enzyme in-
hibitor or -blocker were adopted as an afterload-reducing
therapy. These strategies during right heart bypass surgery
are thought to improve the clinical results and long-term
outcomes of Fontan candidates.
We clearly demonstrated impaired LV performance in
patients with PA/IVS after BDG and TCPC. Nevertheless,
these findings have some limitations. First, the approxima-
tion of Ees and Ea in this study has inherent limitations and
is not equivalent to the measurement by conductance cath-
eter. This study was designed to apply the concepts of Ees,
Ea, and Ea/Ees to the patients with PA/IVS and patients
with TA by using the conventional cardiac catheterization
data before and after the right heart bypass surgery. We
believe that the problem of the approximation in this study
does not detract from the validity of our conclusions. Sec-
ond, correlation of LV performance and RV–coronary ar-
tery fistulas in patients with PA/IVS should be analyzed.
However the detail analysis could not be performed in this
study group because of our small number of patients. In this
study, there was no significant difference in LV perfor-
mance between patients with PA/IVS with and without
important RV–coronary artery fistulas after right heart by-
pass surgery. Further comparative studies of patients with
PA/IVS with and without important RV–coronary artery are
therefore needed. Finally, the long-term changes of LV
performance (Ees, Ea, Ea/Ees, and SW/PVA) are the next
important area to address. We worry about the poor long-
The Journal of Thoraciterm outcome in LV performance we saw in patients with
PA/IVS who underwent right heart bypass surgery.
In conclusion, contractility and ventricular efficiency of
patients with PA/IVS are inferior to those of patients with
TA after BDG and TCPC. Ischemic damage of the LV
myocardium as a result of coronary artery obstructive le-
sions in association with the RV–coronary artery fistulas is
an important factor in, but is not always the main reason for,
impaired LV performance in patients with PA/IVS. A high-
pressure residual RV might impair LV performance in pa-
tients with PA/IVS after BDG and TCPC. Before any de-
finitive conclusions can be made, however, long-term
evaluations of LV performance in patients with PA/IVS
remain to be performed in future follow-up studies.
This study was prepared in consultation with Tomomi Yamada,
MS, Department of Medical Information Science Kyushu Univer-
sity Hospital, for statistical analyses.
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Discussion
Dr David P. Bichell (San Diego, Calif). Congratulations on an
excellent presentation of this important step toward understanding
the complexity of single-ventricle mechanics.
With estimates of ventricular efficiency that you validated in
your own previous work, you’ve elegantly demonstrated that,
relative to a cohort of patients with TA, the PA/IVS septum group
showed worsening of contractility and ventricular efficiency with
time after the BDG and Fontan operations, although the groups
performed quite similarly in the pre-BDG state.
I have three questions, which I’ll present individually. First, can
you comment on why the disparity in the function between the two
groups begins only after the BDG? If the effect of the hypertensive
RV and its interaction on the LV is a major contributing factor to
the decrement in LV function, shouldn’t that relationship exist
before the BDG? Why would the difference evolve only years
later?
Dr Tanoue. As you pointed out, ventricular septum interaction
between the right and LV by hypertensive RV should occur before
BDG. In this study, however, LV performance before BDG was
not different between the patients with PA/IVS and the patients
with TA. The influence of the high-pressure RV on the LV
performance would be relatively slight in an early age and would
increase with growth.
Although many questions remain unanswered regarding the
exact mechanism of impaired LV function in patients with PA/IVS
after right heart bypass surgery, the long-term evaluations of the
LV performance in patients with PA/IVS are significantly impor-
tant. We worry about the poor long-term outcome in the LV
performance we saw in patients with PA/IVS who underwent right
heart bypass surgery
Dr Bichell. Second, it has been shown in previous studies that
in the single LV, diastolic and systolic functions normalize if the
volume unloading procedure, the BDG, is performed when the
patient is younger than 12 months, whereas persistent abnormali-
ties in ventricular function exist if the volume unloading is later. It
has also been shown that late exercise capacity is better in those
who have volume unloading earlier.
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DYour mean ages were 3 years at BDG construction and 5 years
at the Fontan. Have you looked at the ventricular efficiency mea-
surements with respect to the timing of the BDG? In other words,
do patients with earlier timing fair better in ventricular function
with time?
Dr Tanoue. I agree that right heart bypass surgery should be
performed as early as possible. In this series, for historical reason,
relatively old series were included, leading to a relatively old
average age.
The preservation of the ventricular function by relieving the
volume load on the single ventricles should be performed in an
early stage. Recently, we have performed BDG in the early stage
insofar as possible. In this series, however, only 4 patients from
each group underwent BDG at younger than 12 months. So the
specifications in timing of BDG and TCPC could not be examined
because of our small number of patients.
Dr Bichell. Finally, you allude in the article to RV decompres-
sion in patients with PA/IVS who were on the Fontan pathway.
Sano’s group has published impressive improvements in LV end-
diastolic dimension and stroke volume with a complete resection
of the free wall of the RV in a different model of RV failure
affecting the LV. In PA/IVS, however, decompression of the RV
has demonstrably resulted in a worsening of LV function, presum-
ably because of coronary compromise.
Can you comment on your experience with decompressing
these little ventricles in the PA/IVS group on the Fontan pathway?
What are your recommendations for decompressing them, and
what have your results been?
Dr Tanoue. We think the high-pressure RV is one of the most
important factors for impaired LV function in patients with PA/
IVS. But this remains only a speculation. Recently, we have
performed RV outflow tract reconstruction at BDG to decompress
the high-pressure RV in a patient with PA/IVS who was a Fontan
candidate and did not have any RV–coronary artery fistulas.
Now, only a few patients with PA/IVS who were Fontan
candidates have undergone RV outflow tract reconstruction, so we
cannot truly analyze the experience and the effect of the RV
decompression on LV performance in patients with PA/IVS. We
do, however, recommend the decompression of the hypertensive
RV in patients with PA/IVS at right heart bypass surgery if there’s
no RV–coronary artery fistula.
Dr Frank Hanley (Stanford, Calif). I’m left with a bit of
uncertainty as to how your conclusions relate to the difference
between PA/IVS and TA and whether there is actually some
component of a relatively long-standing systemic-pulmonary arte-
rial shunt as a factor. All your patients with PA/IVS had a rela-
The Journal of Thoracitively long-standing systemic-pulmonary arterial shunts. Only half
of your patients with TA did. It would seem that you could
eliminate that confounding variable either by comparing just the
patients with shunts in the TA group with your patients with
PA/IVS or alternatively by looking at just the patients with TA and
comparing those with and without shunts and seeing whether there
is any difference. This would eliminate a chronic systemic shunt as
a factor in the depressed long-term ventricular function.
Dr Tanoue. Previous procedures before BDG is an important
factor, but that analysis was not performed because of the small
number of patients.
Dr Hanley. You have all the data to look at it.
Dr John E. Mayer, Jr (Boston, Mass). What technique of CPB
did you use when you constructed your bidirectional cavopulmo-
nary shunt and your Fontan total cavopulmonary anastomosis type
of procedure? Did you crossclamp the aorta? If you did, what
method did you use for myocardial preservation, or did you do
these in beating-heart preparations?
How did you manage CPB in terms of keeping the RV full?
Because I think we’ve anecdotally had experience that even if you
don’t crossclamp the aorta in patients with RV-dependent coronary
circulation, if you don’t keep the heart full, you can see the
electrocardiograms start to change immediately as soon as you
decompress the right heart by taking away the venous return. So
could you elaborate on the techniques that you’ve used for CPB in
these cases?
Dr Tanoue. In patients with PA/IVS with important coronary
artery obstructive lesions in association with the RV–coronary
artery fistulas, the institution of CPB is very dangerous because
cardiac ischemia may occur. In our hospital, after institution of
CPB, aortic clamping is performed immediately and cardioplegia
is infused. We have no experience of the ischemic problem from
RV–coronary fistulas.
Dr Mayer. I only ask because I wonder whether in the subset
of patients who have RV-dependent coronary circulation the long-
term worse LV function is due to the way you’ve handled the
coronary circulation and myocardial preservation at the time of
your initial operation. I think, without seeing the individual data
points and the relationship of those individual patients to the
patients with RV-dependent coronary circulation, that it becomes
hard to understand what the impact is on the interaction of those
two factors.
Dr Tanoue. In this series, there was no significant difference in
SW/PVA 1 year after TCPC between patients with PA/IVS with
and without important RV–coronary artery fistulas.
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